Written answers

Tuesday, 19 February 2019

Department of Health

Medicinal Products Availability

Photo of Willie O'DeaWillie O'Dea (Limerick City, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

328. To ask the Minister for Health the status of the approval of the drug Spinraza for availability under the general medical services system; and if he will make a statement on the matter. [7727/19]

Photo of Seán HaugheySeán Haughey (Dublin Bay North, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

383. To ask the Minister for Health if the drug known as Spinraza will be made available to persons with spinal muscular atrophy; and if he will make a statement on the matter. [8009/19]

Photo of Peadar TóibínPeadar Tóibín (Meath West, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

388. To ask the Minister for Health when Spinraza treatment will be rolled out to persons with spinal muscular atrophy; and if he will make a statement on the matter. [8028/19]

Photo of Seán SherlockSeán Sherlock (Cork East, Labour)
Link to this: Individually | In context | Oireachtas source

395. To ask the Minister for Health when a drug (details supplied) will be made available. [8119/19]

Photo of Denis NaughtenDenis Naughten (Roscommon-Galway, Independent)
Link to this: Individually | In context | Oireachtas source

415. To ask the Minister for Health when a decision will be made on making Spinraza available to children with spinal muscular atrophy; and if he will make a statement on the matter. [8205/19]

Photo of Robert TroyRobert Troy (Longford-Westmeath, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

434. To ask the Minister for Health the status of the application for reimbursement for Nusinersen for the treatment of spinal muscular atrophy; if he has engaged with the HSE in an effort to advance this process; and if he will make a statement on the matter. [8324/19]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 328, 383, 388, 395, 415 and 434 together.

The Health Service Executive has statutory responsibility for decisions on pricing and reimbursement of medicines, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013.

The Act specifies the criteria to be applied in the making of reimbursement decisions which include the clinical and cost effectiveness of the product, the opportunity cost and the impact on resources that are available to the HSE.

I am advised by the HSE that the application for the reimbursement of Nusinersen (Spinraza) was considered by HSE Leadership at a meeting on 12 February 2019 and that the HSE is in the process of communicating its decision to the relevant company.

Comments

No comments

Log in or join to post a public comment.